AGBT: Pacific Biosciences Offers More Info on Onso Short-Read Sequencer Performance, Pricing
The firm also revealed consumables reagent kit pricing for the instrument, which uses a new sequencing-by-binding method that PacBio says provides high accuracy.
Foundation Medicine, Natera Launch Early Access for Clinical Personalized ctDNA Monitoring Test
The personalized and targeted tumor assay, also available for research use in clinical trials, provides a surrogate measure of tumor burden from blood samples.
Glioblastoma With Wild-Type TP53 Linked to Potentially Targetable Epigenetic Alteration
With the help of a CRISPR-based screen, researchers linked enhanced activity by the chromatin regulatory gene BRD8 to altered p53 function in cells containing wild-type TP53.
Japanese Lung Cancer Genomic Screening Project Expands in Asia-Pacific
LC-SCRUM-Asia, a genomic screening project and database that initially launched in Japan in 2013, is expanding and will cover additional countries in the Asia-Pacific region.
Studies Assess Tumor Aneuploidy to Guide Immunotherapy Treatment
Results from two new studies suggest that tumor aneuploidy can provide an additional layer of information to help predict response to checkpoint blockade immunotherapy.